Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort A updated results
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-07-01
|
| Series: | European Urology Open Science |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168320331645 |
| id |
doaj-08f97e7f76174b1e9aeba4c51c46fe8e |
|---|---|
| record_format |
Article |
| spelling |
doaj-08f97e7f76174b1e9aeba4c51c46fe8e2020-12-30T04:15:48ZengElsevierEuropean Urology Open Science2666-16832020-07-0119e873e874Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort A updated resultsJ.M. PiulatsE. YuG. GravisB. LaguerreJ. ArranzS. OudardP. FongM. KolinskyM. AugustinS. FeyerabendA.. KamH. GurneyA. TafreshiM. RetzW. BerryN. MarH. WuC. SchlossC. PoehleinJ. De Bonohttp://www.sciencedirect.com/science/article/pii/S2666168320331645 |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
J.M. Piulats E. Yu G. Gravis B. Laguerre J. Arranz S. Oudard P. Fong M. Kolinsky M. Augustin S. Feyerabend A.. Kam H. Gurney A. Tafreshi M. Retz W. Berry N. Mar H. Wu C. Schloss C. Poehlein J. De Bono |
| spellingShingle |
J.M. Piulats E. Yu G. Gravis B. Laguerre J. Arranz S. Oudard P. Fong M. Kolinsky M. Augustin S. Feyerabend A.. Kam H. Gurney A. Tafreshi M. Retz W. Berry N. Mar H. Wu C. Schloss C. Poehlein J. De Bono Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort A updated results European Urology Open Science |
| author_facet |
J.M. Piulats E. Yu G. Gravis B. Laguerre J. Arranz S. Oudard P. Fong M. Kolinsky M. Augustin S. Feyerabend A.. Kam H. Gurney A. Tafreshi M. Retz W. Berry N. Mar H. Wu C. Schloss C. Poehlein J. De Bono |
| author_sort |
J.M. Piulats |
| title |
Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort A updated results |
| title_short |
Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort A updated results |
| title_full |
Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort A updated results |
| title_fullStr |
Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort A updated results |
| title_full_unstemmed |
Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort A updated results |
| title_sort |
pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castration-resistant prostate cancer (mcrpc): keynote-365 cohort a updated results |
| publisher |
Elsevier |
| series |
European Urology Open Science |
| issn |
2666-1683 |
| publishDate |
2020-07-01 |
| url |
http://www.sciencedirect.com/science/article/pii/S2666168320331645 |
| work_keys_str_mv |
AT jmpiulats pembrolizumabpembroplusolaparibindocetaxelpretreatedpatientsptswithmetastaticcastrationresistantprostatecancermcrpckeynote365cohortaupdatedresults AT eyu pembrolizumabpembroplusolaparibindocetaxelpretreatedpatientsptswithmetastaticcastrationresistantprostatecancermcrpckeynote365cohortaupdatedresults AT ggravis pembrolizumabpembroplusolaparibindocetaxelpretreatedpatientsptswithmetastaticcastrationresistantprostatecancermcrpckeynote365cohortaupdatedresults AT blaguerre pembrolizumabpembroplusolaparibindocetaxelpretreatedpatientsptswithmetastaticcastrationresistantprostatecancermcrpckeynote365cohortaupdatedresults AT jarranz pembrolizumabpembroplusolaparibindocetaxelpretreatedpatientsptswithmetastaticcastrationresistantprostatecancermcrpckeynote365cohortaupdatedresults AT soudard pembrolizumabpembroplusolaparibindocetaxelpretreatedpatientsptswithmetastaticcastrationresistantprostatecancermcrpckeynote365cohortaupdatedresults AT pfong pembrolizumabpembroplusolaparibindocetaxelpretreatedpatientsptswithmetastaticcastrationresistantprostatecancermcrpckeynote365cohortaupdatedresults AT mkolinsky pembrolizumabpembroplusolaparibindocetaxelpretreatedpatientsptswithmetastaticcastrationresistantprostatecancermcrpckeynote365cohortaupdatedresults AT maugustin pembrolizumabpembroplusolaparibindocetaxelpretreatedpatientsptswithmetastaticcastrationresistantprostatecancermcrpckeynote365cohortaupdatedresults AT sfeyerabend pembrolizumabpembroplusolaparibindocetaxelpretreatedpatientsptswithmetastaticcastrationresistantprostatecancermcrpckeynote365cohortaupdatedresults AT akam pembrolizumabpembroplusolaparibindocetaxelpretreatedpatientsptswithmetastaticcastrationresistantprostatecancermcrpckeynote365cohortaupdatedresults AT hgurney pembrolizumabpembroplusolaparibindocetaxelpretreatedpatientsptswithmetastaticcastrationresistantprostatecancermcrpckeynote365cohortaupdatedresults AT atafreshi pembrolizumabpembroplusolaparibindocetaxelpretreatedpatientsptswithmetastaticcastrationresistantprostatecancermcrpckeynote365cohortaupdatedresults AT mretz pembrolizumabpembroplusolaparibindocetaxelpretreatedpatientsptswithmetastaticcastrationresistantprostatecancermcrpckeynote365cohortaupdatedresults AT wberry pembrolizumabpembroplusolaparibindocetaxelpretreatedpatientsptswithmetastaticcastrationresistantprostatecancermcrpckeynote365cohortaupdatedresults AT nmar pembrolizumabpembroplusolaparibindocetaxelpretreatedpatientsptswithmetastaticcastrationresistantprostatecancermcrpckeynote365cohortaupdatedresults AT hwu pembrolizumabpembroplusolaparibindocetaxelpretreatedpatientsptswithmetastaticcastrationresistantprostatecancermcrpckeynote365cohortaupdatedresults AT cschloss pembrolizumabpembroplusolaparibindocetaxelpretreatedpatientsptswithmetastaticcastrationresistantprostatecancermcrpckeynote365cohortaupdatedresults AT cpoehlein pembrolizumabpembroplusolaparibindocetaxelpretreatedpatientsptswithmetastaticcastrationresistantprostatecancermcrpckeynote365cohortaupdatedresults AT jdebono pembrolizumabpembroplusolaparibindocetaxelpretreatedpatientsptswithmetastaticcastrationresistantprostatecancermcrpckeynote365cohortaupdatedresults |
| _version_ |
1724366811069153280 |